Polycystic ovary syndrome (PCOS) is associated with NASH severity and advanced fibrosis

Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database

(2018) Balachandran Kumarendran et al.   PLOS MEDICINE

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

(2017) Naga Chalasani et al.   HEPATOLOGY

The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis

(2016) Gurkan Bozdag et al.   HUMAN REPRODUCTION

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME -PART 2

(2015) Neil F. Goodman et al.   Endocrine Practice

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 1

(2015) Neil F. Goodman et al.   Endocrine Practice

Reanalyzing the modified Ferriman-Gallwey score: is there a simpler method for assessing the extent of hirsutism?

(2011) Heather Cook et al.   FERTILITY AND STERILITY

Non-alcoholic steatohepatitis (NASH) in patients with polycystic ovarian syndrome (PCOS)

(2010) Noreen Hossain et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Apoptotic Markers Indicate Nonalcoholic Steatohepatitis in Polycystic Ovary Syndrome

(2009) Susanne Tan et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM